Novocure (NVCR) Tops Q1 EPS by 6c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $131.45 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• CVG to join Russell 2000 and Russell 3000 indexes June 26